PEG MGF
PEGylated MGF with extended systemic half-life for broader research applications.
How it works
PEGylation reduces renal clearance and prolongs availability of the MGF E-domain sequence.
Reported benefits
- Systemic exposure for muscle repair studies
- Less frequent dosing than native MGF
Dosage & administration
Research range: 200 mcg subcutaneously 1-2x weekly.
Dosing information is summarised from published clinical and pre-clinical literature for research purposes only and does not constitute medical advice.
Safety & warnings
- Pre-clinical data only
- Use under research supervision
For research use. Consult a licensed clinician before any human application. Not for use in pregnancy, lactation, or active malignancy without specialist supervision.
Available presentations
2 mg
FMP2
Box of 10 · $270
Single vial · $540
Related guides
BPC 157
A pentadecapeptide derived from human gastric juice with broad regenerative effects in pre-clinical models.
TB500 (Thymosin B4 Acetate)
A synthetic fragment of thymosin β-4 that promotes cell migration, angiogenesis, and tissue repair.
BPC + TB Blend
Combined BPC 157 and TB500 blend used in recovery protocols to overlap angiogenic and cytoskeletal effects.